Jerold Martin Named Manufacturing Thought Leader of the Decade by
BioProcess International Magazine
PORT WASHINGTON, N.Y., October 18, 2012 -
Pall Corporation (NYSE:PLL)
and its leadership team have been instrumental in the shift toward
single-use manufacturing in the biopharmaceutical industry. This
critical role was recognized by BioProcess International (BPI) with its
announcement that Pall’s Jerold Martin was named Thought Leader of
the Decade in the Manufacturing Pillar category of the magazine’s
Honoring a Decade of BioProcess Awards.
Jerold Martin, Sr. Vice President for Global Scientific Affairs, Pall BioPharmaceuticals (Photo: Business Wire)
2012 BioProcess International Awards were created to celebrate
BioProcess International's 10-year anniversary and recognize the
outstanding products, services, partnerships and people that have had
the greatest positive impact on the “three pillars” of bioprocessing.
Winners and finalists were honored by their peers last week at an awards
dinner and ceremony as part of the 2012 BioProcess International
Conference and Exhibition in Providence, Rhode Island.
Mr. Martin, Sr. Vice President for Global Scientific Affairs, Pall
BioPharmaceuticals, was recognized by the independent judging
committee for his visionary leadership and advocacy efforts related to
single-use biomanufacturing. He is a frequent speaker and author on the
application of single-use technologies and topics related to filtration
and aseptic processing. He also led the Bio-Process Systems Alliance
(BPSA) trade association in developing a series of consensus
best-practice guides that have become broadly accepted.
“This is a well-deserved honor,” said Yves Baratelli, President, Pall
Life Sciences. “Jerry was at the forefront of the bioprocessing
industry’s shift toward a single-use manufacturing paradigm. He also has
been an essential voice for Pall, bringing attention to our
trend-setting work in single-use and disposable technologies.”
Over the last 10 years, Pall has led the charge in commercializing single-use
technologies that are now widely used in the development and
manufacturing of biopharmaceuticals. Pall’s single-use product solutions
have helped companies improve the cost of capital and add flexibility to
their manufacturing operations while allowing them to be more
competitive in an evolving global marketplace. Innovations from Pall
include the first large scale Kleenpak™ capsule filters and sterile
connectors, Allegro™ biocontainers and systems, Mustang® chromatography
membranes and Cadence™ in-line concentrators.
Pall and its biopharmaceutical leaders have brought clarity to the
technical challenges and questions related to the use of single-use
disposables in the production of biopharmaceuticals. From assisting with
the qualification and validation of single-use systems to navigating
regulatory requirements and addressing disposal questions, Pall experts
have played a key role in the adoption of this emerging trend.
In addition to Mr. Martin’s Thought Leader of the DecadeAward
in the Manufacturing Pillar category, Pall Corporation is associated
with several other honorees in the BioProcess Awardscompetition.
Ireland’s National Institute for Bioprocessing Research and Training
(NIBRT), who Pall
has partnered with on industry training efforts, was the winner in
the Manufacturing Collaboration of the Decade Award.
GlaxoSmithKline and Pfenex Inc. were named finalists in the Upstream
Technical Application of the Decade category for their
implementation of Pall’s Micro-24 scaleable, disposable 10 mL bioreactor
technology (developed by MicroReactor Technologies). Mr. Martin was also
a finalist for the Thought Leader of the Decade Awards in the
Upstream and Downstream Pillar categories.
Mr. Martin has more than 35 years of experience in microbiology and
technical services, R&D, technical marketing, and industry/regulatory
liaison. He has co-authored numerous PDA Technical Reports, BPSA Guides
and ASTM, ISO and ASME-BPE Standards in the field. He has conducted
training seminars around the world for industry and regulatory agencies
including US FDA, EMA, Ireland IMB, Korea FDA, China SFDA, Japan MHLW
and Australia TGA. He currently serves as Chairman of the Board of BPSA,
the single-use biopharma manufacturing trade association, and is also an
active member of ASME-BPE, ISPE and PDA, where he received the 2007
Distinguished Service Award.
About Pall Corporation
Pall Corporation (NYSE:
PLL) is a filtration, separation and purification leader providing
solutions to meet the critical fluid management needs of customers
across the broad spectrum of life sciences and industry. Pall works with
customers to advance health, safety and environmentally responsible
technologies. The Company’s engineered products enable process and
product innovation and minimize emissions and waste. Pall Corporation is
an S&P 500 company serving customers worldwide. Pall has been named a
“top green company” by Newsweek magazine. To see how Pall is
helping enable a greener, safer, more sustainable future, follow us on
or visit www.pall.com/green.